Use of a 6-miRNA panel to distinguish lymphoma from reactive lymphoid hyperplasia

Abstract excerpt

Lymphoma is a systemic malignancy originating from the lymphatic system, and it accounts for 3–4% of all tumors. In the United States, lymphoma is ranked 5th among the top causes of cancer deaths, and an estimated 80,500 new cases were diagnosed in 2017. 1 Successful treatment relies largely on the correct diagnosis and subclassification of lymphoma in surgically excised biopsies based on cell morphology,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Immune Cell Function and Interaction
• Share to Lymphoma Diagnosis and Treatment
• Share to NF-κB Signaling Pathways